• Title/Summary/Keyword: 코스닥기업

Search Result 229, Processing Time 0.027 seconds

Convertible Debt Issuance and A Firm's Growth (전환사채 발행과 기업의 성장성)

  • Jung, Moo-Kwon;Cha, Myung-Jun
    • The Korean Journal of Financial Management
    • /
    • v.26 no.3
    • /
    • pp.1-29
    • /
    • 2009
  • Since convertible debt has both characteristics of stocks and bonds, its issuance can be related to both interests of stockholders and bondholders. Nevertheless, the existing studies focused mainly on the wealth effect on stockholders. In this paper we revisit the hypotheses on the issue of convertible debt especially from the viewpoint of a firm's growth, by making an additional investigation into bondholders' wealth effects. We find that stockholders' wealth increases with bondholders' wealth in the firm whose book-to-market ratio is low and thus is considered a growth firm. This finding seems consistent with the hypothesis in which the issue of convertible debt mitigates the agency cost of debt in the high-growth firm.

  • PDF

A study on the influences of KOSDAQ listed venture firms' financing method on management accomplishments (코스닥등록 벤처기업의 자본조달방식이 경영성과에 미치는 영향)

  • Mo, Kang-Kyung;Yang, Hae-Sool
    • Journal of the Korea Academia-Industrial cooperation Society
    • /
    • v.8 no.6
    • /
    • pp.1625-1633
    • /
    • 2007
  • In this paper, influences of financing method on management accomplishments for KOSDAQ listed venture firms has been objectively verified. The results of this study revealed that explanatory variable had significant influences on management outcomes of firms, and some part of pecking order theory has not gotten the supported result and other part has gotten the supported result. Also, it was analyzed that fixed asset investment had significant influences on management accomplishments.

  • PDF

The Effect of New Product Development Activity on New Product Development Performance (신제품 개발활동이 신제품 개발 성과에 미치는 영향)

  • Rhee, Doyun;Ha, Kyu Soo
    • Asia-Pacific Journal of Business Venturing and Entrepreneurship
    • /
    • v.9 no.6
    • /
    • pp.183-198
    • /
    • 2014
  • This study analyzed the effect of NPD(New Product Development) strategy and standardized NPD activity on NPD performance in KODAK companies. As a result of this study, companies with a specific NPD strategy that can lead and integrate NPD programs were 48.5% and companies without NPD strategy were 51.5% among KOSDAQ companies, which showed that companies without NPD programs were relatively higher than companies with NPD programs. According to result of NPD performance, success rate of new product showed 51.2% and success rate of new product revenue showed 44.87%, but respondents who evaluated NPD performance as "very successful" and "successful" were 53% based on the study of 77 various industries by Kuczmarski & Associates in America in 1993, and the companies in this study showed relatively below-average marks to the result of the study examined by USA PDMA in 1995 as compared to 59% of NPD success rate according to the 2nd study of best practice in 1995 by USA PDMA(Product Development & Management Association). As a result of testing the difference between NPD performances depending on whether company has NPD strategy or not, it showed a significant difference in success rate of NPD depending on NPD strategy and had a higher success rate of NPD as company has NPD strategy. Although NPD activity does not provide with documented process, companies which follow clearly recognized procedure until individual business for product development is completed were 39.6%, indicating that KOSDAQ companies still have fewer standardized NPD procedure than USA companies with 76% as compared to the result of 1990 PDMA in America. As a result of ANOVA test, NPD success rate showed the difference depending on the presence of officially documented process. As a result of Scheffe and Bonferroni test as post hoc test, companies with officially documented process, carrying out a series of business in a given section showed a higher NPD success rate by 18.385 at the 5% significance level than companies with individual business procedure without officially documented process. The difference of this research from the previous studies is that the findings of PDMA in America throughout the United States were applied to the domestic KOSDAQ companies. In addition, the existing studies related to NPD in Korea were conducted for some limited industries in the past, but this study was applied to various industries of KOSDAQ companies. The implications of this study suggest that it is necessary for KOSDAQ Industry Association or other related governmental departments to educate and guide the standardized process about NPD for increasing survival rate and reinforcing competitiveness of the companies.

  • PDF

A Morphological Analysis of Korean Business Names (한국 기업 이름의 형태론적 연구)

  • Kang, Eungyeong
    • The Journal of the Korea Contents Association
    • /
    • v.20 no.10
    • /
    • pp.157-166
    • /
    • 2020
  • This study is a descriptive analysis of Korean business names listed on KOSDAQ (Korea Securities Dealers Automated Quotation) from a morphological perspective. A total of 1,358 business names on KOSDAQ are collected and analyzed in terms of origins and morphological structure. The analysis exhibits the monopoly of English: only 20% of the names are composed of only Korean elements, including Sino-Chinese, while 76% of them contain some form of English elements. It is pointed out that those English elements are not borrowed from English but are created in Korea and participate further word formation processes. In terms of word formation methods, compounding and shortening are most common, taking up 90% of all names. Multiple derived forms are used from an identical origin word, and even bound forms in English are taken and used as independent words, regardless of their original status in English. It is argued that Korean English is not entirely negative and should be considered as part of World Englishes.

기획 / 상장 기업 분석

  • Sin, Jong-Hun
    • Digital Contents
    • /
    • no.12 s.127
    • /
    • pp.60-69
    • /
    • 2003
  • 2003년은 디지털콘텐츠 업계에도 주식시장 상장 바람이 강력하게 불었다. 웹젠, 유엔젤, 거원시스템, 지식발전소 등 새롭게 상장된 기업의 수는 적었지만, 웹젠이 코스닥 시장에 상장하면서 일으킨‘대박’이라는 폭풍은 관련 업계 관계자들을 들뜨게 만들었다. 하지만 올해 상장한 기업들이 모두‘한몫’을 잡은 것은 아니다. 올해 주식시장을 뜨겁게 달궜던 디지털콘텐츠 기업들의 성적표를 살펴봤다.

  • PDF

Venture Portfolio-온라인 채용 문화의 글로벌 패러다임을 이끈다 인크루트 이광석 대표

  • Korea Venture Business Association
    • Venture DIGEST
    • /
    • s.95
    • /
    • pp.8-11
    • /
    • 2006
  • 사람에게는 업(業)을, 기업에게는 인재를 주선하는 '일과 사람의 포털' 사이트가 있다. 1998년 우리나라 최초로 온라인 채용 시스템을 개설해 국내 취업시장의 판도를 재편한 인크루트는 꾸준한 성장세를 유지하며 동종업계 최초로 코스닥에 상장되는 등 취업·인사 전문기업으로써의 위상을 떨치고 있다. 경쟁보다는 협력의 전략을, 속도보다는 정도의 경영을 강조하는 이광석 대표에게 인크루트의 글로벌 전략과 비전을 들어보았다.

  • PDF

Business Guide_업체탐방 - "미래와 자연을 생각하는 기업" - (주)무경 -

  • 한국전기제품안전협회
    • Product Safety
    • /
    • s.195
    • /
    • pp.38-41
    • /
    • 2010
  • 21세기 환경 및 에너지, 위생 분야를 선도하는 미래를 생각하는 기업인 주식회사 무경은 중소기업으로써 5년 이내 코스닥 상장을 목표로 모든 임직원 일동이 한마음으로 끊임없는 기술개발과 품질보증의 생활화를 통하여 장인정신으로 제품을 개발하고 있는 건실한 기업이다. 꾸준히 발전하고 있는 (주)무경의 대표이사를 찾아가 인터뷰해 보았다.

  • PDF

A Study on Improvement of the KONEX, the Emerging Exchange for SMEs and Startups (코넥스(KONEX)시장의 재도약을 위한 제도개선 연구)

  • Kim, Yun Kyung;Shin, Hyun-Han;Joe, Byoung-Moon
    • Asia-Pacific Journal of Business Venturing and Entrepreneurship
    • /
    • v.17 no.1
    • /
    • pp.177-189
    • /
    • 2022
  • This study proposes policy recommendations for the Korea New Exchange ("KONEX"), which is a financial platform for SMEs and startups that relied on indirect and policy financing in the past. SMEs and venture firms with limited human and physical listing resources can grow through market incubation, and venture capitalists expect an early exit or return on investment. However, the lack of liquidity and sluggish trading volume have weakened the function of the market. Despite prior policy efforts, the number of newly listed companies has decreased while listing demand for KOSDAQ and K-OTC has increased. This study aims to suggest short- and long-term improvements in regulations and throughout the KONEX firms' listing life cycle. First, the minimum deposit requirement on individual investors should be abolished to increase the number of investors. Second, information disclosure should be conducted by firms so that the nominated advisor can focus on discovering and supporting new listed companies. Third, in order to increase trading volume, the 5% dispersion rule should be changed to 25% dispersion incentive principle. Fourth, a new track without profit condition in expedited transfer listing should be introduced because the KOSDAQ relaxes the profit realization requirements for listing. Lastly, transfer listing without additional review for firms that fulfill ownership dispersion, information disclosure, and investor protection will strengthen the incubating role of the KONEX.

Effect of Cash flow on the R&D investment of Pharmaceutical Companies - focused on KOSDAQ market (제약회사의 현금흐름이 연구개발투자에 미치는 영향 -코스닥시장을 중심으로)

  • Lee, Munjae;Choi, Mankyu
    • The Journal of the Korea Contents Association
    • /
    • v.15 no.8
    • /
    • pp.473-480
    • /
    • 2015
  • The purpose of this study is to analyze the influence of the cash flow of pharmaceutical companies on R&D investment. 143 pharmaceutical companies listed in the KOSDAQ market from 2009 to 2013. Financial statements and comments in general and internal transactions were extracted from TS-2000 of the Korea Listed Company Association (KLCA), and data related to stock price was extracted from KISVALUE-III of NICE Information Service Co., Ltd. STATA 12.0 was used as the statistical package for panel analysis. The summary of the findings and the interpretation of the significance of this are as follows: First, the current ratio (internal finance) had a positive influence on R&D investment. Second, the debt ratio (external finance) had a negative influence on R&D investment. The pharmaceutical company prefers internal funds to external funds due to the asymmetry of information in the loan markets. In other words, this shows why internal finances have a significant influence on R&D investment at pharmaceutical companies.